MINK THERAPEUTICS, INC. (INKT)
MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury
MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury
DEFSEC Technologies Inc. Announces Third Quarter Fiscal 2026 Results
UTStarcom Announces Finance Leadership Changes
Asset Acquisitions and Disposals: ANNOUNCEMENT PURSUANT TO RULE 706A OF THE LISTING MANUAL
Accelerant Announces Second Quarter 2026 Results
Financial Statements and Related Announcement: Half Yearly Results
Financial Statements and Related Announcement: Half Yearly Results
McGraw Hill, Inc. Reports Strong Fiscal First Quarter 2027 Results Exceeding Expectations
Mandatory Cash Dividend/ Distribution:
Financial Statements and Related Announcement: Half Yearly Results